WINNERGY MEDICAL PUBLIC COMPANY LIMITEDSET: WINMED🇹🇭 TH

Risk Management · 2025

Risk Management Policy & Plan

Policy & Plan Description

The Company and its subsidiaries are committed to comprehensive risk management in order to strengthen business resilience and enable sustainable growth amid challenges and rapid changes. The Company focuses on three key dimensions as follows:

  • Risk-Aware Culture: The Company promotes risk management as a responsibility of personnel at all levels so that the organization can professionally respond to uncertainties while transforming challenges into opportunities for value creation for the business.

  • Governance in line with international standards: Under the policy of the Board of Directors, the Risk Management Committee has implemented modern monitoring and evaluation systems to systematically and effectively oversee emerging risks in economic, social, and environmental aspects.

  • Clear and tangible objectives: The Company focuses on controlling impacts within acceptable levels in order to safeguard the best interests of shareholders and stakeholders, while ensuring the continuity and sustainability of the Company’s operations

The Board of Directors has therefore appointed the Company’s Risk Management Committee to manage risks in a systematic manner in accordance with international standards by applying the Committee of Sponsoring Organizations of the Treadway Commission (COSO ERM Framework – 2017) together with sustainability principles under the Environmental, Social and Governance (ESG) framework. Senior executives from various functions of the Company have been appointed as the Risk Management Working Team to plan, manage, and control risks affecting the Company’s business operations to ensure that such risks remain at appropriate and acceptable levels.

Risks to the Company's Business Operations

Risk Register

Risk NameRisk CharacteristicsConsequencesRelated Risk Factors
Risks Related to Business and Operations of the Company

1. Risks Related to Medical Device Distribution and Procurement from Overseas Manufacturers

The Company operates as a distributor of medical devices and equipment sourced from several leading international manufacturers and product owners. Such distributorship arrangements are governed by contractual agreements with specified terms, which may be subject to change based on mutually agreed conditions.

Potential risks include changes in manufacturers’ policies or marketing strategies, such as direct distribution to customers in Thailand without intermediaries, increases in product costs, appointment of additional distributors within the same territory, or organizational changes such as mergers and acquisitions. In addition, failure by either party to comply with contractual terms may result in termination of distributorship agreements. There is also the possibility that other operators may import similar products from the same manufacturers, leading to increased competition. If the Company is unable to renew distributorship agreements, this could directly impact its revenue and operating performance.

To mitigate these risks, the Company places strong emphasis on continuous human capital development, particularly for sales and marketing personnel with extensive experience. Regular training programs are conducted to enhance product knowledge and modern marketing strategies, enabling employees to effectively apply their expertise in business operations.

The Company’s key customer base includes both public hospitals and leading private hospitals, where successful product distribution requires expertise in sales, regulatory knowledge, and understanding of procurement processes in Thailand.

In 2025, the Company actively engaged with overseas manufacturers to maintain strong business relationships and increase opportunities to secure exclusive distributorship rights for selected products in Thailand. The Company also expanded its business collaborations and maintained close coordination with partners to ensure consistent product availability.

Furthermore, the Company diversifies risk by distributing products from multiple manufacturers and brands, reducing dependency on any single supplier. This strategy not only supports revenue growth but also enhances business resilience. The Company also continues to strengthen its sales team capabilities and expand its market presence across both existing and new customer segments.

2. Risks from Business Competition

In 2025, the medical device industry continues to demonstrate steady growth, driven by increasing demand for medical technologies and the expansion of healthcare services across both public and private sectors. However, the number of market participants has also increased, intensifying competition. Some competitors import similar or substitute products from other manufacturers, while price competition and ongoing innovation provide customers with a wider range of choices. Additionally, the growing role of online distribution platforms has further intensified market accessibility and competition.

To maintain its competitive advantage, the Company focuses on selecting and distributing high-quality products from reputable manufacturers recognized both locally and internationally. The management team and personnel possess extensive industry experience, enabling effective product presentation and a deep understanding of product applications, as well as procurement processes within government and healthcare institutions.

The Company positions itself as a solution provider, offering comprehensive services ranging from product consultation and technical support to after-sales service. This approach enhances customer satisfaction and fosters long-term relationships.

Moreover, the Company has been appointed as a distributor for multiple medical device brands, increasing product variety and customer options. The business development team continuously explores new technologies and products, while also expanding distribution channels and service models to better meet evolving market demands.

The Company also adheres to international standards to ensure operational excellence and safety, including ISO 9001:2015 (Quality Management), ISO 13485:2016 (Medical Device Quality Management), ISO 39001:2012 (Road Safety Management), ISO 45001:2018 (Occupational Health and Safety), Good Distribution Practice (GDP), and ISO/IEC 27001 (Information Security Management). These standards support quality control across all processes and strengthen confidence among customers and stakeholders.

As a listed company, the Company emphasizes transparency, good corporate governance, and continuous improvement of products and services, aiming to build long-term business relationships under a sustainable win-win approach.
3. Risks from Reliance on Government and Major Customers

The Company provides products and services to both public and private sector customers. Historically, a significant portion of revenue was derived from government customers, as public healthcare institutions are key users of medical devices in Thailand.

However, the Company has implemented strategies to diversify its customer base by offering a wide range of products to serve public hospitals, private hospitals, and other healthcare institutions. This approach reduces dependency on any single customer group.

As of 2025, the Company does not rely significantly on any specific government or private customer. Although many customers belong to the public sector, each organization operates independently in terms of budgeting and procurement decisions. Therefore, changes in purchasing by any single entity are unlikely to materially impact the Company’s overall operations.

Through customer diversification and continuous product development, the Company effectively manages risks related to reliance on government and major customers, ensuring such risks do not have a significant impact on its business.

If the Company is unable to renew its distributorship agreements, or if manufacturers change their business policies—such as shifting to direct sales, appointing additional distributors, or adjusting product pricing—the Company may lose distribution rights for certain products. This could impact its revenue, operating performance, and competitive position.

In addition, increasing competition in the medical device industry in terms of pricing, technology, and distribution channels may place pressure on pricing and profit margins, and could affect market share if the Company is unable to adapt its strategies or develop products and services in line with evolving market conditions.

Furthermore, changes in government budget policies, delays in procurement processes, or budget constraints within public sector organizations may reduce opportunities for product sales and participation in bidding projects, which could affect the Company’s revenue and operating performance during certain periods.

734 · Description: Reliance on large customers or few customers · Info category: STRATEGIC_RISK · 1714 · Description: Competition risk · Info category: STRATEGIC_RISK · 737 · Other name: Risk relating to the Company’s role as a distributor of medical devices and equipment and the procurement of products from major overseas medical device manufacturers · Description: Other · Info category: STRATEGIC_RISK
Financial Risk

1. Risk of Delayed Payments from Government Customers

As a portion of the Company’s customers consists of government and public sector entities, payment processes are subject to official budget disbursement procedures, which may take longer than those of private sector customers. This may pose liquidity management risks and result in additional financial costs due to delayed payments.

However, in 2025, the Company effectively managed its financial liquidity by incorporating potential financing costs arising from extended payment terms into its product pricing. In addition, procurement by government hospitals typically requires prior project approval and budget allocation, providing reasonable assurance that payments will be fully received once the disbursement process is completed.

The Company also maintains a policy of granting credit only to creditworthy customers, supported by financial assessments based on reliable historical and current data. Furthermore, a systematic receivables monitoring process is in place, including regular reporting on payment status and outstanding receivables to management and relevant departments, ensuring effective credit risk management.

2. Risk from Foreign Exchange Rate Fluctuations

As the Company imports medical devices and equipment from overseas, certain payments are made in foreign currencies, exposing the Company to exchange rate fluctuations. Significant currency movements may increase import costs and impact profitability.

To mitigate this risk, the Company has implemented appropriate foreign exchange risk management practices, including the use of hedging instruments and policies to manage currency volatility. Forward foreign exchange contracts are monitored and controlled, with regular reporting of gains or losses to management. These instruments are used solely to manage risk within acceptable levels and not for speculative purposes.

Additionally, the Company negotiates with certain suppliers to conduct transactions in Thai Baht through local representatives. As a result, management considers foreign exchange risk to be manageable and not materially impactful to the Company’s operations.

3. Risk from Rising Interest Rates

The Company has borrowings from financial institutions, including both short-term and long-term loans, making it susceptible to interest rate fluctuations that may affect financial costs.

In 2025, the Company maintained effective financial management through the use of appropriate tools and strategies, along with continuous monitoring of interest rate trends. Risk management measures are in place to address potential volatility, including negotiations with financial institutions to secure fixed interest rates for long-term loan facilities.

Delayed payments from government customers, due to budget disbursement procedures under public sector regulations, may extend the Company’s collection period. This could impact cash flow management and financial liquidity, and may result in higher financing costs during certain periods.

In addition, fluctuations in foreign exchange rates related to imported goods may lead to changes in import costs, potentially affecting profit margins and the Company’s operating performance if currency movements are significant.

At the same time, rising interest rates may increase the Company’s financial costs due to its existing loan obligations, which could impact net profit and the Company’s ability to manage its financial structure in the long term.

764 · Description: Fluctuation in exchange rates, interest rates, or the inflation rate · Info category: FINANCIAL_RISK · 767 · Other name: Risk from Delayed Payments by Government Customers · Description: Other · Info category: FINANCIAL_RISK
Operation Risk

1. Risk from Dependence on Personnel

The Company’s business operations in the distribution of medical devices and equipment rely on personnel with specialized knowledge, expertise, and experience in customer coordination, product presentation, consultation, and after-sales service. Therefore, human resources are a critical factor in the Company’s success.

To mitigate this risk, the Company places strong emphasis on continuous human resource management and development. Employees are encouraged to develop multitasking skills to enhance their capabilities and enable role substitution where necessary. The Company also offers appropriate compensation and benefits to attract and retain qualified personnel for long-term growth.

In addition, the Company focuses on improving standardized and systematic work processes to reduce reliance on individual employees. Supporting tools and operational processes have been developed to enhance team efficiency, including the Customer Critical Pain Points (CCPP) system, which enables the Company to track customer needs, gather feedback, and maintain strong relationships with both existing and potential customers.

2. Risk from Digital Technology Changes and Cybersecurity Threats

Rapid advancements in digital technology have improved business efficiency and operations. However, increased reliance on information systems and data connectivity also exposes the Company to cybersecurity risks, such as system breaches, unauthorized access, and data leakage, which could disrupt operations and compromise data security.

The Company prioritizes information security management by engaging specialized IT service providers to oversee cybersecurity. This includes planning, monitoring, and implementing appropriate security tools to assess and enhance system protection.

Continuous system monitoring is conducted through computer traffic logging and security alert systems. Regular cybersecurity training and assessments are also provided to employees to enhance awareness and promote safe system usage.

Additionally, the Company has established a Business Continuity Plan (BCP) to address potential disruptions to IT systems and business operations. The plan is regularly tested and reviewed to ensure operational continuity during unforeseen events.

The Company is also certified under ISO/IEC 27001 (Information Security Management System: ISMS), an international standard that ensures systematic data protection across confidentiality, integrity, and availability. This strengthens trust among customers, partners, and stakeholders.

3. Risk Related to Corporate Reputation and Image

The Company emphasizes ethical conduct, whistleblowing mechanisms, and complaint handling processes. Appropriate channels and procedures are in place, along with regular monitoring of news and public information. The Company actively communicates and provides clarifications to relevant stakeholders to maintain and protect its corporate reputation and image.

4. Risk in Compliance with Regulations and Laws

The Company operates under various laws and regulations, including the Medical Device Act B.E. 2551 (2008), Ministry of Public Health regulations, announcements of the Thai Food and Drug Administration (FDA), and the Product Liability Act B.E. 2551 (2008). Compliance is essential to ensure business operations and consumer protection.

Failure to comply, whether due to operational errors or lack of awareness, may result in significant business impacts. For example, failure to renew import licenses for medical devices could lead to suspension of product imports by authorities, affecting product delivery and future business performance.

As government entities are key customers, the Company must strictly comply with public procurement regulations, including e-market and e-bidding systems, and continuously monitor procurement announcements.

In 2025, internal and external audits confirmed that the Company operated in full compliance with applicable laws and regulations, with no significant violations identified.

5. Risk Related to Human Rights

The Company recognizes its responsibility to uphold human rights and has formalized this commitment within its Code of Conduct. The Company promotes respect, equality, and non-discrimination regardless of gender, race, nationality, religion, or culture, and does not engage in or support any activities that violate human rights.

Although the Company has not yet fully implemented a comprehensive Human Rights Due Diligence (HRDD) process in line with regulatory guidelines, it has assessed human rights risks that may impact reputation, branding, marketing, and financial performance in accordance with its risk management policies.

Dependence on personnel with specialized knowledge, expertise, and experience may pose a risk if key employees are lost or if the Company is unable to retain qualified personnel. This could affect operational efficiency, customer service quality, and the Company’s competitiveness.

In addition, rapid changes in digital technology and cybersecurity threats may expose the Company to risks related to data and information system security. Unauthorized access or cyberattacks could disrupt operations, damage critical data, and impact the confidence of customers and business partners.

At the same time, failure to fully comply with applicable laws and regulations, or incidents that negatively affect the Company’s reputation and corporate image, may result in legal risks, potential suspension of certain business operations, or loss of trust from customers, partners, and stakeholders, which could impact the Company’s long-term performance.

756 · Description: Change in laws and regulations · Info category: COMPLIANCE_RISK · 738 · Description: Reliance on employees in key positions · Info category: OPERATIONAL_RISK · 757 · Description: Laws and regulations is not favorable for doing business · Info category: COMPLIANCE_RISK · 758 · Description: Violations of laws and regulations · Info category: COMPLIANCE_RISK · 736 · Description: Damage to company image and reputation · Info category: STRATEGIC_RISK · 753 · Description: Impact on human rights · Info category: OPERATIONAL_RISK · 755 · Other name: Risks from Changes in Digital Technology and Cybersecurity Threats · Description: Other · Info category: OPERATIONAL_RISK
Environmental, Social and Governance Issues : ESG Risk

Environmental, Social, and Governance (ESG) considerations have become critical factors in risk management, as they may impact an organization’s competitiveness, profitability, corporate image and reputation, as well as stakeholder confidence in the long term. The Company therefore places importance on integrating sustainability risk management into its mission, corporate strategy, and risk management processes at all levels.

The Company conducts systematic assessments and analyses of sustainability risks through Sustainability Risk and Materiality Analysis. The results are used to support planning and the development of appropriate risk management approaches, enabling the business to grow in a balanced manner while creating value for stakeholders.

In addition, the Company has established a sustainability working committee to drive and continuously develop ESG-related initiatives. The Company focuses on raising awareness of sustainable development among employees at all levels and promotes responsible business practices aligned with social responsibility and good corporate governance.

The Company has also defined a meaningful business purpose for each business segment to inspire and guide operations, emphasizing not only financial performance but also the creation of positive impacts on communities, society, and the environment.

Failure to effectively manage Environmental, Social, and Governance (ESG) issues may negatively impact the Company’s corporate image and reputation, as well as the confidence of stakeholders, including customers, partners, investors, and society at large. It may also affect the Company’s competitiveness and long-term business opportunities.

At the same time, insufficient focus on sustainable business practices may hinder the Company’s ability to adapt to evolving stakeholder expectations and future business trends, potentially impacting its sustainable growth and long-term performance.

751 · Description: Impact on the environment · Info category: OPERATIONAL_RISK
Compliance Risk

In terms of corporate governance, the Company has further strengthened its internal audit system and compliance oversight to ensure adherence to relevant laws and regulations. This is to ensure that the Company’s operations are conducted in accordance with the principles of good corporate governance, with transparency and appropriate social responsibility. In addition, the Company continuously improves its internal processes and develops sustainability policies in collaboration with various departments within the organization to ensure that its operations align with the Company’s mission and objectives.

The Company is committed to conducting its business based on the principles of good corporate governance, emphasizing responsible business practices, respect for human rights, and strict compliance with applicable laws and government regulations. This commitment applies not only to the Company’s own operations but also to the operations of its business partners within the supply chain, in order to support the Company’s sustainable growth in the long term.

If the Company is unable to conduct its business in accordance with good corporate governance principles, or fails to comply with applicable laws, regulations, and requirements, it may face legal and regulatory risks, which could also negatively impact its corporate image and stakeholder confidence.

In addition, if the Company’s operations or those of its supply chain partners do not align with social responsibility and human rights principles, this may affect the Company’s reputation and business relationships with customers, partners, and stakeholders, potentially impacting its operations and sustainable long-term growth.

756 · Description: Change in laws and regulations · Info category: COMPLIANCE_RISK · 759 · Description: Corporate Governance · Info category: COMPLIANCE_RISK

Risks to Securities Holders' Investment

Risk Register

Risk NameRisk CharacteristicsConsequencesManagement MeasuresRelated Risk Factors
The Company’s major shareholders include the founding family group, which held 182,785,820 shares as of 31 December 2025, representing 45.70% of the Company’s total issued and paid-up shares.

Major shareholders have the authority to determine the Company’s policies and business direction, as well as to vote on significant matters of the Company.

The major shareholder group can oppose or block the approval of resolutions at shareholders’ meetings on matters that, under the Company’s Articles of Association or applicable laws, require not less than one-third of the total votes of shareholders present and eligible to vote.

The major shareholder group places strong emphasis on the governance of the Company in terms of both policy and operational practices. Accordingly, any actions related to the Company’s business are undertaken with due consideration for the best interests of all shareholders.

2970 · Description: Risk of the company having a majority shareholder holding > 25% of shares · Info category: HOLDER_RISK
Contents